Global Radiotherapy Market -Industry Trends and Forecast to 2024
Report Code: HC-R-17-04-DB-145.

Global Radiotherapy Market is expected to reach USD  5.3 billion  by 2024, at a CAGR of 7.5% in the forecast period 2017 to 2024. The report contains 276 pages of exclusive premium insights with 284 tables and 56 figures.

Cancer is the major cause of death in the world and the number of new patients each year is steadily increasing. The most common form of cancer mortality is by metastasis, where the tumours and cancerous cells spread to organs causing failure. The world is focused upon developing solutions and cure to cancer by destroying primary and secondary tumours that cause metastasis. In current healthcare scenario localized treatment of tumours the only efficient treatment for tumours. Radiosurgery is used alongside surgery or separately to treat cancer for a long time. More than 75% of the cancer patient population is expected to take radiosurgery in some point of their disease prognosis.

Buy Now


Clear selection

"Get Notified On all out New and Upcoming Reports"

       on all the latest research reports

Global Radiotherapy Market is expected to reach USD  5.3 billion  by 2024, at a CAGR of 7.5% in the forecast period 2017 to 2024. The report contains 276 pages of exclusive premium insights with 284 tables and 56 figures.

Cancer is the major cause of death in the world and the number of new patients each year is steadily increasing. The most common form of cancer mortality is by metastasis, where the tumours and cancerous cells spread to organs causing failure. The world is focused upon developing solutions and cure to cancer by destroying primary and secondary tumours that cause metastasis. In current healthcare scenario localized treatment of tumours the only efficient treatment for tumours. Radiosurgery is used alongside surgery or separately to treat cancer for a long time. More than 75% of the cancer patient population is expected to take radiosurgery in some point of their disease prognosis.

Title

Pages

Price

Cart

BUY FULL REPORT

276

$4200

Buy-Now

Table of Contents

 

 

1. INTRODUCTION

1.1. OVERVIEW OF THE RADIOTHERAPY MARKET

 

1.2. MARKET SEGMENTATION & COVERAGE

 

1.2.1. CURRENCY AND PRICING

 

1.2.2. LIMITATION

 

2. RESEARCH METHODOLOGY

2.1. KEY TAKEAWAYS

 

2.2. ARRIVING AT THE RADIOTHERAPY MARKET SIZE

 

2.2.1. MARKET CRACKDOWN APPROACH

 

2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

 

2.2.3. DATA TRIANGULATION

 

2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES

 

2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES

 

2.2.6. PORTER’S FIVE FORCES MATRIX

 

2.2.7. PEST ANALYSIS

 

2.2.8. EPIDEMIOLOGY FORECASTING MODELS

 

2.3. GLOBAL RADIOTHERAPY MARKET: RESEARCH SNAPSHOT

 

2.4. ASSUMPTIONS

 

3. MARKET LANDSCAPE SUMMARY

4. PREMIUM INSIGHTS

4.1. OVERVIEW

 

4.2. RADIOTHERAPY MARKET: KEY PRIMARY INSIGHTS

 

4.3. MARKET OVERVIEW

 

4.3.1. DRIVERS

 

4.3.2. RESTRAINTS

 

4.3.3. OPPURTUNITIES

 

4.3.4. THREATS

 

4.4. KEY MARKET FINDINGS

 

4.5. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

 

5. RADIOTHERAPY MARKET, BY THERAPY TYPE

5.1. OVERVIEW

 

5.2. BEAM RADIOTHERAPY

 

5.2.1. IMAGE-GUIDED RADIOTHERAPY (IGRT)

 

5.2.2. INTENSITY MODULATED RADIOTHERAPY (IMRT)

 

5.3.3. VOLUMETRIC MODULATED ARC THERAPY (VMAT)

 

5.3.4. TOMOTHERAPY

 

5.3.5. STEREOTACTIC TECHNOLOGY

 

5.3.6. 3D CONFORMAL RADIOTHERAPY

 

5.2. BRACHYTHERAPY

 

5.2.1. LOW DOSE RATE (LDR)

 

5.2.2. HIGH DOSE RATE (HDR)

 

5.4. SYSTEMIC RADIOTHERAPY

 

6. RADIOTHERAPY MARKET, BY PRODUCT TYPE

6.1. OVERVIEW

 

6.2. EXTERNAL BEAM RADIOTHERAPY EQUIPMENT

 

6.2.1. CYBERKNIFE

 

6.2.2. GAMMAKNIFE

 

6.2.3. LINAC

 

6.2.4. PROTON BEAM

 

6.2.4.1.      CYCLOTRON

 

6.2.4.2.      SYNCLOTRON

 

6.3.         INTERNAL RADIOTHERAPY PRODUCTS

 

6.3.1. SEEDS

 

6.3.2. AFTERLOADERS

 

6.3.3. OTHERS

 

6.4. RADIOTHERAPY SOFTWARES

 

6.4.1. TREATMENT PLANNING SOFTWARES

 

6.4.2. DOSAGE PLANNING SOFTWARES

 

6.4.3. PATEINT POSITIONING SOFTWARES

 

6.4.4. IMAGE GUIDING SOFTWARES

 

6.5. SYSTEMIC RADIOTHERAPY

 

7. RADIOTHERAPY MARKET, BY INDICATION

7.1. OVERVIEW

 

7.2. BRAIN TUMOR

 

7.3. SPINE CANCER

 

7.4. LUNG CANCER

 

7.5. LIVER CANCER

 

7.6. BREAST TUMOR

 

7.7. PROSTRATE CANCER

 

7.8. OTHERS

 

8. RADIOTHERAPY MARKET, BY GEOGRAPHY

8.1. COUNTRYWISE RADIOTHERAPY MARKET,  (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

 

8.1.1. NORTH AMERICA

 

8.1.1.1.      U.S.

 

8.1.1.2.      CANADA

 

8.1.1.3.      MEXICO

 

8.1.2. EUROPE

 

8.1.2.1.      GERMANY

 

8.1.2.2.      FRANCE

 

8.1.2.3.      U.K.

 

8.1.2.4.      ITALY

 

8.1.2.5.      SPAIN

 

8.1.2.6.      RUSSIA

 

8.1.2.7.      TURKEY

 

8.1.2.8.      BELGIUM

 

8.1.2.9.      NETHERLANDS

 

8.1.2.10.    SWITZERLAND

 

8.1.2.11.    REST OF EUROPE

 

8.1.3. ASIA-PACIFIC (APAC)

 

8.1.3.1.      JAPAN

 

8.1.3.2.      CHINA

Global Radiotherapy Market is expected to reach USD  5.3 billion  by 2024, at a CAGR of 7.5% in the forecast period 2017 to 2024. The report contains 276 pages of exclusive premium insights with 284 tables and 56 figures.

Cancer is the major cause of death in the world and the number of new patients each year is steadily increasing. The most common form of cancer mortality is by metastasis, where the tumours and cancerous cells spread to organs causing failure. The world is focused upon developing solutions and cure to cancer by destroying primary and secondary tumours that cause metastasis. In current healthcare scenario localized treatment of tumours the only efficient treatment for tumours. Radiosurgery is used alongside surgery or separately to treat cancer for a long time. More than 75% of the cancer patient population is expected to take radiosurgery in some point of their disease prognosis.

The global radiotherapy market is segmented based on therapy, the market is segmented into external beam radiotherapy, internal beam radiotherapy, and systemic radiation therapy.

Based on product type the global radiotherapy market is segmented into EBRT equipment’s, and IBRT equipment’s. The External Beam Radiotherapy (EBRT) products are further segmented into cyberknife, gammaknife, LINAC, Proton Beam (Cyclotron, Synclotron). The Internal Beam Radiotherapy (IBRT) is segmented into seeds, afterloaders and others.

The global radiotherapy market is also segmented based on indication into cancer of different organs such as brain tumour, spine cancer, lung cancer, liver cancer, breast cancer, prostate cancer and others.

Based on mode of administration the market is segmented into skin, circulatory, organs and central nervous system.

The global radiotherapy market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. These regions are further classified on the basis of country, into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.

 

Major Players Operating in this market:

CIVCO Medical Solutions, Brainlab AG, C. R. Bard, Inc., IsoRay Medical, Inc., Nordion, Inc., RaySearch Laboratories AB, PRECISIS AG, Mevion Medical Systems, Inc., Technicas Radiofiscas S.L., Hitachi, Ltd., Sumitomo Heavy Industries, Ltd., Mitsubishi Electric Corporation, ProNova Solutions, LLC, ProTom International among others.

Regions Covered In The Scope Of The Report:

Global (North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Russia, Belgium, Netherlands, Switzerland, Turkey, Rest of Europe), Asia-Pacific (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC), South America (Brazil, Rest of South America).